{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:30:06Z","timestamp":1792697406167,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002630","name":"Ewha Womans University","doi-asserted-by":"publisher","award":["1-2024-1070-001-1"],"award-info":[{"award-number":["1-2024-1070-001-1"]}],"id":[{"id":"10.13039\/501100002630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00284-025-04334-7","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:08:03Z","timestamp":1750730883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of Penicillin-Non-Susceptible, Multidrug-Resistant Streptococcus agalactiae Using Whole-Genome Sequencing"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-4351","authenticated-orcid":false,"given":"Junghun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-3008","authenticated-orcid":false,"given":"Min-Kyung","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-9264","authenticated-orcid":false,"given":"Yu-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6382-4099","authenticated-orcid":false,"given":"Hae-Sun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"4334_CR1","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","volume":"10","author":"BP Goncalves","year":"2022","unstructured":"Goncalves BP, Procter SR, Paul P et al (2022) Group B Streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health 10:e807\u2013e819. https:\/\/doi.org\/10.1016\/S2214-109X(22)00093-6","journal-title":"Lancet Glob Health"},{"key":"4334_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","volume":"7","author":"VN Raabe","year":"2019","unstructured":"Raabe VN, Shane AL (2019) Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr 7:10\u20131128. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0007-2018","journal-title":"Microbiol Spectr"},{"key":"4334_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5145\/ACM.2023.26.3.1","volume":"26","author":"K Widyasari","year":"2023","unstructured":"Widyasari K, Kim S (2023) Group B Streptococcus vaccines: progress and potential. Ann Clin Microbiol 26:41\u201350. https:\/\/doi.org\/10.5145\/ACM.2023.26.3.1","journal-title":"Ann Clin Microbiol"},{"key":"4334_CR4","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","volume":"135","author":"Committee","year":"2020","unstructured":"Committee (2020) Prevention of group B streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. Obstet Gynecol 135:e51\u2013e72. https:\/\/doi.org\/10.1097\/AOG.0000000000003668","journal-title":"Obstet Gynecol"},{"key":"4334_CR5","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/AAC.00185-08","volume":"52","author":"K Kimura","year":"2008","unstructured":"Kimura K, Suzuki S, Wachino J, Arakawa Y et al (2008) First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890\u20132897. https:\/\/doi.org\/10.1128\/AAC.00185-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jac\/dkp458","volume":"65","author":"C Gaudreau","year":"2010","unstructured":"Gaudreau C, Lecours R, Ismail J, Gagnon S, Jette L, Roger M (2010) Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother 65:594\u2013595. https:\/\/doi.org\/10.1093\/jac\/dkp458","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR7","doi-asserted-by":"publisher","first-page":"574e577","DOI":"10.1016\/j.cmi.2017.02.021","volume":"23","author":"BJ Metcalf","year":"2017","unstructured":"Metcalf BJ, Chochua S, Gertz RE Jr et al (2017) Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect 23:574e577\u2013574e514. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.021","journal-title":"Clin Microbiol Infect"},{"key":"4334_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","volume":"39","author":"A Yi","year":"2019","unstructured":"Yi A, Kim CK, Kimura K, Arakawa Y, Hur M, Yun YM, Moon HW (2019) First case in Korea of group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X. Ann Lab Med 39:414\u2013416. https:\/\/doi.org\/10.3343\/alm.2019.39.4.414","journal-title":"Ann Lab Med"},{"key":"4334_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkz465","volume":"75","author":"M van der Linden","year":"2020","unstructured":"van der Linden M, Mamede R, Levina N, Martins ER et al (2020) Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany. J Antimicrob Chemother 75:296\u2013299. https:\/\/doi.org\/10.1093\/jac\/dkz465","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR10","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/microorganisms8071055","volume":"8","author":"C Li","year":"2020","unstructured":"Li C, Sapugahawatte DN, Yang Y, Wong KT, Lo NWS, Ip M (2020) Multidrug-resistant Streptococcus agalactiae strains found in human and fish with high penicillin and cefotaxime non-susceptibilities. Microorganisms 8:1055. https:\/\/doi.org\/10.3390\/microorganisms8071055","journal-title":"Microorganisms"},{"key":"4334_CR11","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/jac\/dkv203","volume":"70","author":"T Seki","year":"2015","unstructured":"Seki T, Kimura K, Reid ME, Arakawa Y et al (2015) High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother 70:2725\u20132728. https:\/\/doi.org\/10.1093\/jac\/dkv203","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2025.40.e29","volume":"40","author":"A Shin","year":"2025","unstructured":"Shin A, Kim DR, Sung JH, Kim YJ et al (2025) Group B Streptococcus detection rate and clindamycin resistance among reproductive-age women in Korea during 2003\u20132022. J Korean Med Sci 40:e29. https:\/\/doi.org\/10.3346\/jkms.2025.40.e29","journal-title":"J Korean Med Sci"},{"key":"4334_CR13","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1007\/s10096-012-1685-8","volume":"31","author":"M Ki","year":"2012","unstructured":"Ki M, Srinivasan U, Oh KY, Foxman B et al (2012) Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea. Eur J Clin Microbiol Infect Dis 31:3199\u20133205. https:\/\/doi.org\/10.1007\/s10096-012-1685-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4334_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3349\/ymj.2022.63.8.717","volume":"63","author":"HG Bae","year":"2022","unstructured":"Bae HG, Hong J, Kim YJ, Lee KR, Lee K, Choi SJ, Uh Y (2022) A retrospective national study on colonization rate and antimicrobial susceptibility of Streptococcus agalactiae in pregnant Korean women, 2018\u20132020. Yonsei Med J 63:717\u2013723. https:\/\/doi.org\/10.3349\/ymj.2022.63.8.717","journal-title":"Yonsei Med J"},{"key":"4334_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.719353","volume":"12","author":"O Tulyaprawat","year":"2021","unstructured":"Tulyaprawat O, Pharkjaksu S, Shrestha RK, Ngamskulrungroj P (2021) Emergence of multi-drug resistance and its association with uncommon serotypes of Streptococcus agalactiae isolated from non-neonatal patients in Thailand. Front Microbiol 12:719353. https:\/\/doi.org\/10.3389\/fmicb.2021.719353","journal-title":"Front Microbiol"},{"key":"4334_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/jac\/dky542","volume":"74","author":"M Kitamura","year":"2019","unstructured":"Kitamura M, Kimura K, Ido A, Arakawa Y et al (2019) Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan. J Antimicrob Chemother 74:931\u2013934. https:\/\/doi.org\/10.1093\/jac\/dky542","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkr546","volume":"67","author":"N Nagano","year":"2012","unstructured":"Nagano N, Nagano Y, Toyama M, Kimura K, Tamura T, Shibayama K, Arakawa Y (2012) Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1. J Antimicrob Chemother 67:849\u2013856. https:\/\/doi.org\/10.1093\/jac\/dkr546","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/22221751.2018.1557987","volume":"8","author":"H Moroi","year":"2019","unstructured":"Moroi H, Kimura K, Kotani T, Arakawa Y et al (2019) Isolation of group B Streptococcus with reduced beta-lactam susceptibility from pregnant women. Emerg Microbes Infect 8:2\u20137. https:\/\/doi.org\/10.1080\/22221751.2018.1557987","journal-title":"Emerg Microbes Infect"},{"key":"4334_CR19","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/jac\/dkv022","volume":"70","author":"K Kimura","year":"2015","unstructured":"Kimura K, Nagano N, Arakawa Y (2015) Classification of group B streptococci with reduced beta-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs. J Antimicrob Chemother 70:1601\u20131603. https:\/\/doi.org\/10.1093\/jac\/dkv022","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10096-021-04321-3","volume":"41","author":"N Nishiyama","year":"2022","unstructured":"Nishiyama N, Kinjo T, Uechi K, Parrott G, Nakamatsu M, Tateyama M, Fujita J (2022) Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens: a case-control study. Eur J Clin Microbiol Infect Dis 41:1\u20138. https:\/\/doi.org\/10.1007\/s10096-021-04321-3","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4334_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00568-22","volume":"10","author":"S Koide","year":"2022","unstructured":"Koide S, Nagano Y, Takizawa S, Nagano N et al (2022) Genomic traits associated with virulence and antimicrobial resistance of invasive group B Streptococcus isolates with reduced penicillin susceptibility from elderly adults. Microbiol Spectr 10:e0056822. https:\/\/doi.org\/10.1128\/spectrum.00568-22","journal-title":"Microbiol Spectr"},{"key":"4334_CR22","unstructured":"CLSI (2024) Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne"},{"key":"4334_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00203-023-03760-0","volume":"206","author":"YH Kim","year":"2023","unstructured":"Kim YH, Park J, Chung HS (2023) Genetic characterization of tetracycline-resistant Staphylococcus aureus with reduced vancomycin susceptibility using whole-genome sequencing. Arch Microbiol 206:24. https:\/\/doi.org\/10.1007\/s00203-023-03760-0","journal-title":"Arch Microbiol"},{"key":"4334_CR24","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1128\/AAC.00596-08","volume":"52","author":"N Nagano","year":"2008","unstructured":"Nagano N, Nagano Y, Kimura K, Tamai K, Yanagisawa H, Arakawa Y (2008) Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:4258\u20134267. https:\/\/doi.org\/10.1128\/AAC.00596-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10096-022-04505-5","volume":"41","author":"H Lee","year":"2022","unstructured":"Lee H, Kim ES, Song KH, Kim HB, Park JS, Park KU (2022) Clinical and molecular epidemiology of invasive group B Streptococcus infections in adults in a referral center in Korea. Eur J Clin Microbiol Infect Dis 41:1407\u20131413. https:\/\/doi.org\/10.1007\/s10096-022-04505-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4334_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1186\/s12879-024-09625-1","volume":"24","author":"JH Choi","year":"2024","unstructured":"Choi JH, Kim TH, Kim ET, Kim YR, Lee H (2024) Molecular epidemiology and virulence factors of group B Streptococcus in South Korea according to the invasiveness. BMC Infect Dis 24:740. https:\/\/doi.org\/10.1186\/s12879-024-09625-1","journal-title":"BMC Infect Dis"},{"key":"4334_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00595-23","volume":"61","author":"RM Humphries","year":"2023","unstructured":"Humphries RM, Lu J, Martin I, Simner PJ et al (2023) Detection of penicillin nonsusceptible Streptococcus agalactiae by laboratories that participate in the College of American Pathologist\u2019s proficiency testing program. J Clin Microbiol 61:e0059523. https:\/\/doi.org\/10.1128\/jcm.00595-23","journal-title":"J Clin Microbiol"},{"key":"4334_CR28","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/jac\/dkt060","volume":"68","author":"K Kimura","year":"2013","unstructured":"Kimura K, Wachino J, Kurokawa H, Arakawa Y et al (2013) High cephalosporin resistance due to amino acid substitutions in PBP1A and PBP2X in a clinical isolate of group B Streptococcus. J Antimicrob Chemother 68:1533\u20131536. https:\/\/doi.org\/10.1093\/jac\/dkt060","journal-title":"J Antimicrob Chemother"},{"issue":"Pt 8","key":"4334_CR29","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1099\/13500872-145-8-1859","volume":"145","author":"P Giammarinaro","year":"1999","unstructured":"Giammarinaro P, Sicard M, Gasc AM (1999) Genetic and physiological studies of the CiaH-CiaR two-component signal-transducing system involved in cefotaxime resistance and competence of Streptococcus pneumoniae. Microbiology 145(Pt 8):1859\u20131869. https:\/\/doi.org\/10.1099\/13500872-145-8-1859","journal-title":"Microbiology"},{"key":"4334_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.693858","volume":"12","author":"LY He","year":"2021","unstructured":"He LY, Le YJ, Guo Z, Li S, Yang XY (2021) The role and regulatory network of the CiaRH two-component system in streptococcal species. Front Microbiol 12:693858. https:\/\/doi.org\/10.3389\/fmicb.2021.693858","journal-title":"Front Microbiol"},{"key":"4334_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2217\/fmb-2019-0002","volume":"14","author":"AR Tierney","year":"2019","unstructured":"Tierney AR, Rather PN (2019) Roles of two-component regulatory systems in antibiotic resistance. Future Microbiol 14:533\u2013552. https:\/\/doi.org\/10.2217\/fmb-2019-0002","journal-title":"Future Microbiol"},{"key":"4334_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51407","author":"SG Palace","year":"2020","unstructured":"Palace SG, Wang Y, Rubin DH, Grad YH et al (2020) RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates. Elife. https:\/\/doi.org\/10.7554\/eLife.51407","journal-title":"Elife"},{"key":"4334_CR33","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1128\/AAC.06077-11","volume":"56","author":"CJ Kristich","year":"2012","unstructured":"Kristich CJ, Little JL (2012) Mutations in the beta subunit of RNA polymerase alter intrinsic cephalosporin resistance in Enterococci. Antimicrob Agents Chemother 56:2022\u20132027. https:\/\/doi.org\/10.1128\/AAC.06077-11","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1128\/AAC.01449-12","volume":"57","author":"YH Lee","year":"2013","unstructured":"Lee YH, Nam KH, Helmann JD (2013) A mutation of the RNA polymerase beta\u2019 subunit (rpoC) confers cephalosporin resistance in Bacillus subtilis. Antimicrob Agents Chemother 57:56\u201365. https:\/\/doi.org\/10.1128\/AAC.01449-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jac\/dks423","volume":"68","author":"K Kimura","year":"2013","unstructured":"Kimura K, Nagano N, Nagano Y, Suzuki S, Wachino J, Shibayama K, Arakawa Y (2013) High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility. J Antimicrob Chemother 68:539\u2013542. https:\/\/doi.org\/10.1093\/jac\/dks423","journal-title":"J Antimicrob Chemother"},{"key":"4334_CR36","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1128\/AAC.01374-16","volume":"60","author":"C Hays","year":"2016","unstructured":"Hays C, Louis M, Plainvert C, Tazi A et al (2016) Changing epidemiology of group B Streptococcus susceptibility to fluoroquinolones and aminoglycosides in France. Antimicrob Agents Chemother 60:7424\u20137430. https:\/\/doi.org\/10.1128\/AAC.01374-16","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1128\/AAC.02317-12","volume":"57","author":"H Wang","year":"2013","unstructured":"Wang H, Zhao C, He W, Ni Y et al (2013) High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. Antimicrob Agents Chemother 57:1538\u20131541. https:\/\/doi.org\/10.1128\/AAC.02317-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR38","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1128\/AAC.47.11.3605-3609.2003","volume":"47","author":"Y Kawamura","year":"2003","unstructured":"Kawamura Y, Fujiwara H, Mishima N, Ezaki T et al (2003) First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob Agents Chemother 47:3605\u20133609. https:\/\/doi.org\/10.1128\/AAC.47.11.3605-3609.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/s1473-3099(02)00369-9","volume":"2","author":"DC Hooper","year":"2002","unstructured":"Hooper DC (2002) Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2:530\u2013538. https:\/\/doi.org\/10.1016\/s1473-3099(02)00369-9","journal-title":"Lancet Infect Dis"},{"key":"4334_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10122316","author":"D Berbel","year":"2022","unstructured":"Berbel D, Gonzalez-Diaz A, Lopez de Egea G, Camara J, Ardanuy C (2022) An overview of macrolide resistance in streptococci: pevalence, mobile elements and dynamics. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms10122316","journal-title":"Microorganisms"},{"key":"4334_CR41","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1128\/AAC.41.12.2719","volume":"41","author":"J Clancy","year":"1997","unstructured":"Clancy J, Dib-Hajj F, Petitpas JW, Yuan W (1997) Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae. Antimicrob Agents Chemother 41:2719\u20132723. https:\/\/doi.org\/10.1128\/AAC.41.12.2719","journal-title":"Antimicrob Agents Chemother"},{"key":"4334_CR42","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18213","volume":"12","author":"CM Ardila","year":"2024","unstructured":"Ardila CM, Yadalam PK, Gonzalez-Arroyave D (2024) Integrating whole genome sequencing and machine learning for predicting antimicrobial resistance in critical pathogens: a systematic review of antimicrobial susceptibility tests. PeerJ 12:e18213. https:\/\/doi.org\/10.7717\/peerj.18213","journal-title":"PeerJ"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-025-04334-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-025-04334-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T03:50:54Z","timestamp":1752810654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-025-04334-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4334"],"URL":"https:\/\/doi.org\/10.1007\/s00284-025-04334-7","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no actual or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Ewha Womans University Seoul Hospital (IRB File No. 2024-02-013).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"344"}}